{"version":"1.0","provider_name":"Ida-Tallinna Keskhaigla","provider_url":"https:\/\/cancer.itk.ee\/ru","title":"Kas sina oled juba s\u00f5eluuringul k\u00e4inud? - Ida-Tallinna Keskhaigla","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"9pn85ViR1u\"><a href=\"https:\/\/cancer.itk.ee\/ru\/2023\/05\/25\/kas-sina-oled-juba-soeluuringul-kainud\/\">\u0412\u044b \u0443\u0436\u0435 \u043f\u0440\u043e\u0448\u043b\u0438 \u0441\u043a\u0440\u0438\u043d\u0438\u043d\u0433\u043e\u0432\u043e\u0435 \u043e\u0431\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cancer.itk.ee\/ru\/2023\/05\/25\/kas-sina-oled-juba-soeluuringul-kainud\/embed\/#?secret=9pn85ViR1u\" width=\"600\" height=\"338\" title=\"\u00abKas sina oled juba s\u00f5eluuringul k\u00e4inud?\u00bb &#8212; Ida-Tallinna Keskhaigla\" data-secret=\"9pn85ViR1u\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/cancer.itk.ee\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/cancer.itk.ee\/wp-content\/uploads\/2023\/06\/pexels-anna-tarazevich-5482991-scaled.jpg","thumbnail_width":2560,"thumbnail_height":1706,"description":"Levinumad pahaloomulised kasvajad on naistel rinnav\u00e4hk ja meestel eesn\u00e4\u00e4rmev\u00e4hk. Nende avastamiseks on s\u00f5eluuringud \u00e4\u00e4rmiselt vajalikud. Igal aastal avastatakse Eestis umbes 9000 esmajuhtu. \u201eMul on hea meel, et Tervisekassa s\u00f5eluuringuid rahastab, aga kurb meel, et seal ei k\u00e4i piisavalt palju inimesi. Keskmiselt umbes 50% kutsututest tulevad uuringutele ja sellest on v\u00e4ga kahju, sest s\u00f5eluuringute eesm\u00e4rgiks ongi [&hellip;]"}